Literature DB >> 34617199

Hormonal response in patients transplanted with cryopreserved ovarian tissue is independent of whether freezing was performed in childhood or adulthood.

V Greve Hornshøj1, M Dueholm1, L S Mamsen2, E Ernst1, C Y Andersen3.   

Abstract

PURPOSE: This study evaluated the concentrations of hormones resulting from the transplantation of ovarian tissue (OTT) in relation to whether the tissue was frozen at a time close to puberty or above the age of 19 years.
METHODS: Six girls and adolescents (aged 9-14 years) who underwent ovarian tissue cryopreservation (OTC) were followed after transplantation in adulthood. After OTT, the women were followed via regular blood samples to evaluate the concentrations of FSH, LH, oestradiol and AMH. Twenty-three women undergoing OTT (aged 19-36 years at the time of OTC) were included as a reference group. All of the women had postmenopausal levels of gonadotropins at the time of transplantation.
RESULTS: The return of FSH and LH to normal premenopausal concentrations in adult women transplanted with ovarian tissue that was frozen at a time close to puberty was similar to the profiles in women from the reference group. Serum AMH levels were below the detection limit (via the Roche Elecsys assay) in many samples, but four out of six young girls showed measurable concentrations. Oestradiol similarly increased in the first 12 weeks following transplantation, after which it tended to be higher in women having frozen tissue in adulthood.
CONCLUSIONS: Ovarian tissue that was excised from girls at a time close to puberty, after which it was frozen and transplanted in adulthood, interacts with pituitary tissue in a similar manner to ovarian tissue that is frozen from adult women. Follicles located in the ovarian tissue from young girls are equally sensitive to gonadotropin stimulation as follicles from adult women when exposed to postmenopausal levels of gonadotropins. This result indicates that it is not the ovaries that require maturation to sustain full reproductive potential but rather proper FSH and LH stimulation. Moreover, these results support the continued use of OTC in young women.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Dynamics of resumption of activity; FSH secretion; Prepubertal girls; Transplantation of ovarian tissue

Mesh:

Substances:

Year:  2021        PMID: 34617199      PMCID: PMC8608935          DOI: 10.1007/s10815-021-02320-z

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  26 in total

Review 1.  Cryopreservation of ovarian tissue for fertility preservation in young female oncological patients.

Authors:  Claus Yding Andersen; Stine Gry Kristensen; Tine Greve; Kirsten Tryde Schmidt
Journal:  Future Oncol       Date:  2012-05       Impact factor: 3.404

2.  Evaluation of the ovarian reserve in women transplanted with frozen and thawed ovarian cortical tissue.

Authors:  Tine Greve; Kirsten Tryde Schmidt; Stine Gry Kristensen; Erik Ernst; Claus Yding Andersen
Journal:  Fertil Steril       Date:  2012-03-15       Impact factor: 7.329

3.  Fertility Preservation in Women.

Authors:  Jacques Donnez; Marie-Madeleine Dolmans
Journal:  N Engl J Med       Date:  2018-01-25       Impact factor: 91.245

Review 4.  Bypassing physiological puberty, a novel procedure of oocyte cryopreservation at age 7: a case report and review of the literature.

Authors:  Foad Azem; Avivit Brener; Gustavo Malinger; Adi Reches; Ariel Many; Yariv Yogev; Yael Lebenthal
Journal:  Fertil Steril       Date:  2020-05-05       Impact factor: 7.329

5.  Evaluation of cryopreserved ovarian tissue from prepubertal patients after long-term xenografting and exogenous stimulation.

Authors:  Valérie Luyckx; Sarah Scalercio; Pascale Jadoul; Christiani Andrade Amorim; Michelle Soares; Jacques Donnez; Marie-Madeleine Dolmans
Journal:  Fertil Steril       Date:  2013-08-13       Impact factor: 7.329

6.  Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.

Authors:  R Abir; I Ben-Aharon; R Garor; I Yaniv; S Ash; S M Stemmer; A Ben-Haroush; E Freud; D Kravarusic; O Sapir; B Fisch
Journal:  Hum Reprod       Date:  2016-02-04       Impact factor: 6.918

7.  Basal lamina characterization in frozen-thawed and long-term grafted human prepubertal ovarian tissue.

Authors:  Charlotte Philippart; Rossella Masciangelo; Alessandra Camboni; Jacques Donnez; Marie-Madeleine Dolmans
Journal:  Reprod Biomed Online       Date:  2021-02-23       Impact factor: 3.828

8.  Successful pregnancy in a woman previously suffering from β-thalassemia following transplantation of ovarian tissue cryopreserved before puberty.

Authors:  Sara J Matthews; Helen Picton; Erik Ernst; Claus Y Andersen
Journal:  Minerva Ginecol       Date:  2018-04-24

9.  Repetitive Maturation of Oocytes From Non-Stimulated Xenografted Ovarian Tissue From a Prepubertal Patient Indicating the Independence of Human Ovarian Tissue.

Authors:  Nathalie Raffel; Laura Lotz; Inge Hoffmann; Jana Liebenthron; Stephan Söder; Matthias W Beckmann; Ralf Dittrich
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-12-18       Impact factor: 2.915

10.  Cryopreservation and transplantation of ovarian tissue: results from one center in the USA.

Authors:  Sherman J Silber; Michael DeRosa; Sierra Goldsmith; Yuting Fan; Leilani Castleman; Jeffrey Melnick
Journal:  J Assist Reprod Genet       Date:  2018-09-25       Impact factor: 3.412

View more
  1 in total

1.  Analysis of Fertility Preservation by Ovarian Tissue Cryopreservation in Pediatric Children in China.

Authors:  Xiangyan Ruan; Jiaojiao Cheng; Juan Du; Fengyu Jin; Muqing Gu; Yanglu Li; Rui Ju; Yurui Wu; Huanmin Wang; Wei Yang; Haiyan Cheng; Long Li; Wenpei Bai; Weimin Kong; Xin Yang; Shulan Lv; Yuejiao Wang; Yu Yang; Xin Xu; Lingling Jiang; Yanqiu Li; Alfred O Mueck
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-29       Impact factor: 6.055

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.